CA3187174A1 - Preparations and compositions comprising polymer combination preparations - Google Patents
Preparations and compositions comprising polymer combination preparationsInfo
- Publication number
- CA3187174A1 CA3187174A1 CA3187174A CA3187174A CA3187174A1 CA 3187174 A1 CA3187174 A1 CA 3187174A1 CA 3187174 A CA3187174 A CA 3187174A CA 3187174 A CA3187174 A CA 3187174A CA 3187174 A1 CA3187174 A1 CA 3187174A1
- Authority
- CA
- Canada
- Prior art keywords
- preparation
- polymer
- polymer combination
- combination preparation
- kda
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063053488P | 2020-07-17 | 2020-07-17 | |
| US63/053,488 | 2020-07-17 | ||
| US202063108861P | 2020-11-02 | 2020-11-02 | |
| US63/108,861 | 2020-11-02 | ||
| PCT/US2021/042110 WO2022016129A1 (en) | 2020-07-17 | 2021-07-17 | Preparations and compositions comprising polymer combination preparations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3187174A1 true CA3187174A1 (en) | 2022-01-20 |
Family
ID=79555039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3187174A Pending CA3187174A1 (en) | 2020-07-17 | 2021-07-17 | Preparations and compositions comprising polymer combination preparations |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230293427A1 (https=) |
| EP (1) | EP4181857A4 (https=) |
| JP (1) | JP2023534504A (https=) |
| KR (1) | KR20230041032A (https=) |
| CN (1) | CN116133642A (https=) |
| AU (1) | AU2021308083A1 (https=) |
| BR (1) | BR112023000190A2 (https=) |
| CA (1) | CA3187174A1 (https=) |
| IL (1) | IL299806A (https=) |
| WO (1) | WO2022016129A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021329884A1 (en) * | 2020-08-17 | 2023-02-16 | SURGE Therapeutics, Inc. | Immune modulation of myeloid derived suppressive cell function for cancer treatment |
| CN114617903B (zh) * | 2022-03-15 | 2024-05-24 | 中国人民解放军总医院第一医学中心 | 一种用于血浆冻干的组合物及其应用 |
| KR20250030440A (ko) * | 2022-04-29 | 2025-03-05 | 바이오데벡 인코포레이티드 | 생체적합성 접착제 물질 및 사용 방법 |
| IT202300004218A1 (it) * | 2023-03-07 | 2024-09-07 | Delim Cosmetics & Pharma S R L | Composizioni termoreversibili e mucoadesive |
| CN116554949A (zh) * | 2023-05-16 | 2023-08-08 | 广州大学 | 一种润滑油添加剂及其制备方法 |
| CN117619361A (zh) * | 2023-12-09 | 2024-03-01 | 中北大学 | 改性高岭土/包覆型高铁酸钾复合材料及其制备方法 |
| CN120324357B (zh) * | 2025-06-03 | 2025-10-24 | 上海国创医药股份有限公司 | 一种普瑞巴林缓释组合物及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002516617A (ja) * | 1995-06-16 | 2002-06-04 | メドロジック グローバル コーポレイション | 反応性ポリマー網状構造体及びその使用法 |
| AU6385796A (en) * | 1995-06-16 | 1997-01-15 | Medlogic Global Corporation | Responsive polymer networks and methods of their use |
| CA2401239A1 (en) * | 2000-03-03 | 2001-09-13 | Valentis, Inc. | Improved poloxamer and poloxamine compositions for nucleic acid delivery |
| US20060034889A1 (en) * | 2004-08-16 | 2006-02-16 | Macromed, Inc. | Biodegradable diblock copolymers having reverse thermal gelation properties and methods of use thereof |
| CN101297973B (zh) * | 2008-05-22 | 2010-06-09 | 武汉华纳生物工程有限公司 | 高生物粘附温敏水凝胶及其制备方法和用途 |
| WO2010088924A1 (en) * | 2009-02-06 | 2010-08-12 | Telormedix Sa | Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration |
| EP2520279A1 (en) * | 2011-05-02 | 2012-11-07 | TERES S.r.l. | Thermoreversible gel pharamaceutical compositions for odontoiatric use |
| CN103055304A (zh) * | 2013-01-19 | 2013-04-24 | 卓阳 | 一种治疗皮肤溃疡用复方温敏凝胶剂及其制备方法 |
| US9364545B2 (en) * | 2014-06-19 | 2016-06-14 | Taipei Medical University | Thermosensitive injectable hydrogel for drug delivery |
| CN104983722A (zh) * | 2015-07-01 | 2015-10-21 | 苏州吉欧生物科技有限公司 | 一种皮肤祛疤修复喷膜剂的组合物及其制备方法 |
| EP3706718A1 (en) * | 2017-11-07 | 2020-09-16 | Royal College of Surgeons in Ireland | A thermo-responsive hydrogel for intratumoral administration as a treatment in solid tumor cancers |
| CN109820816B (zh) * | 2019-02-18 | 2023-04-28 | 江苏拓弘生物科技有限公司 | 温度敏感性生物凝胶制剂及其应用 |
| CN113766929A (zh) * | 2019-05-02 | 2021-12-07 | 斯蒂米特公司 | 癌症治疗 |
| KR102067490B1 (ko) * | 2019-05-21 | 2020-01-20 | 주식회사 티젤바이오 | 서방성 약물전달용 온도상전이 나노 입자/하이드로젤 복합체 |
| US12090205B2 (en) * | 2019-10-28 | 2024-09-17 | Rochal Technologies Llc | Poloxamer compositions with reduced sol-gel transition temperatures and methods of reducing the sol-gel transition temperature of poloxamer compositions |
-
2021
- 2021-07-17 KR KR1020237005332A patent/KR20230041032A/ko active Pending
- 2021-07-17 CN CN202180062155.6A patent/CN116133642A/zh active Pending
- 2021-07-17 EP EP21841706.1A patent/EP4181857A4/en active Pending
- 2021-07-17 US US18/016,096 patent/US20230293427A1/en active Pending
- 2021-07-17 WO PCT/US2021/042110 patent/WO2022016129A1/en not_active Ceased
- 2021-07-17 BR BR112023000190A patent/BR112023000190A2/pt unknown
- 2021-07-17 CA CA3187174A patent/CA3187174A1/en active Pending
- 2021-07-17 JP JP2023503114A patent/JP2023534504A/ja active Pending
- 2021-07-17 IL IL299806A patent/IL299806A/en unknown
- 2021-07-17 AU AU2021308083A patent/AU2021308083A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4181857A1 (en) | 2023-05-24 |
| WO2022016129A1 (en) | 2022-01-20 |
| EP4181857A4 (en) | 2024-08-14 |
| JP2023534504A (ja) | 2023-08-09 |
| IL299806A (en) | 2023-03-01 |
| BR112023000190A2 (pt) | 2023-04-25 |
| KR20230041032A (ko) | 2023-03-23 |
| CN116133642A (zh) | 2023-05-16 |
| US20230293427A1 (en) | 2023-09-21 |
| AU2021308083A1 (en) | 2023-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230293427A1 (en) | Preparations and compositions comprising polymer combination preparations | |
| AU2024267047B2 (en) | Degradable hyaluronic acid hydrogels | |
| US20230398146A1 (en) | Immune modulation of myeloid derived suppressive cell function for cancer treatment | |
| JP2024151337A (ja) | がんの処置 | |
| US20240082236A1 (en) | Cancer therapy | |
| US20250049951A1 (en) | Nucleic acid compositions and uses thereof | |
| AU2022404969A1 (en) | Solid forms of resiquimod and formulations thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250711 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250711 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20250716 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT Effective date: 20250716 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250716 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20250923 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT Effective date: 20250923 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250923 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250923 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250923 |